DOI: 10.1055/s-00032260

Digestive Disease Interventions

Referenz

Shaverdian N, Lisberg AE, Bornazyan K. et al.
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.

Lancet Oncol 2017;
18 (07) 895-903

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in:
Aufrufen in: